Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

University of Alberta

$815,339.00

Cellular lipids in Huntington's disease

FY 2010-11

Summary
Huntington's disease (HD) is the most common inherited neurodegenerative disorder. It is characterized by progressive motor dysfunction, cognitive decline and psychiatric disturbances. There is currently no cure for this disease. The production of certain lipid molecules that are important for normal functioning of brain cells is impaired in HD. The aim of this proposal is to investigate the consequences of reduced lipid synthesis in HD brain and to test whether restoring normal levels of these important neural molecules improves HD symptoms and slows down disease progression. Supported by encouraging preliminary results, our studies will potentially identify new therapeutic interventions for the cure of HD.
Program
Operating Grant
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
212664
Name
Sipione Simonetta
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Systems & Circuits Neurosciences - A
Projecttitle
Cellular lipids in Huntington's disease
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$815,339
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Animal Studies; Cell Biology; Cell Signaling; Gangliosides; Huntington'S Disease; Lipid Metabolism; Neurobiology; Pharmacology
Abstract
Huntington's disease (HD) is the most common inherited neurodegenerative disorder. It is characterized by progressive motor dysfunction, cognitive decline and psychiatric disturbances. There is currently no cure for this disease. The production of certain lipid molecules that are important for normal functioning of brain cells is impaired in HD. The aim of this proposal is to investigate the consequences of reduced lipid synthesis in HD brain and to test whether restoring normal levels of these important neural molecules improves HD symptoms and slows down disease progression. Supported by encouraging preliminary results, our studies will potentially identify new therapeutic interventions for the cure of HD.
Competitiondate
201009
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Sipione, Simonetta
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $815,339~ $0~